メインコンテンツにスキップ
検索

創薬

登録

最新のリソース

注目コンテンツ

Latest discovery blogs

単なるChatGPTではありません：なぜライフサイエンス分野には、ドメイン特化型AIが必要なのか
Not just another ChatGPT: Why life sciences needs domain-specific AIBlog

単なるChatGPTではありません：なぜライフサイエンス分野には、ドメイン特化型AIが必要なのか

Mathematical modeling and the monkey king: Use of modeling for more efficient NHP study design
Mathematical modeling and the monkey king: Use of modeling for more efficient NHP study designBlog

Mathematical modeling and the monkey king: Use of modeling for more efficient NHP study design

4 ways that mechanistic modeling accelerates bispecific (and multispecific) antibody drug development
4 ways that mechanistic modeling accelerates bispecific (and multispecific) antibody drug developmentBlog

4 ways that mechanistic modeling accelerates bispecific (and multispecific) antibody drug development

Quantitative systems pharmacology (QSP) modeling for immunotherapy-induced cytokine release syndrome
Quantitative systems pharmacology (QSP) modeling for immunotherapy-induced cytokine release syndromeBlog

Quantitative systems pharmacology (QSP) modeling for immunotherapy-induced cytokine release syndrome

創薬のためのデータ活用を加速──科学的データへの扉を開くプラットフォーム
Drug discovery platform unlocks scientific data accessBlog

創薬のためのデータ活用を加速──科学的データへの扉を開くプラットフォーム

創薬支援ツールが製薬業界の意思決定をどう支えるか
How drug discovery tools aid pharma decision-makingBlog

創薬支援ツールが製薬業界の意思決定をどう支えるか

以下のイベントで弊社のエキスパートをご紹介

展示会・学会

Discovery on Target 2026

September 28 - 2026年10月1日 – Boston, MA + Virtual – Booth 516
展示会・学会

BioTechX Europe 2026

October 6 - 8, 2026
展示会・学会

ACoP 2026

October 11 - 14, 2026

All Discovery resources

Trusted Cheminformatics, Zero Integration Headaches: ML in Python with Chemaxon

Certara Products, Demo LP - Small Featured, Drug Development, Webinar

Cracking the code on NCA: How Pinnacle 21 helps de-risk PK analyses

Certara Products - Pinnacle 21, Modeling and Simulation - PK/PD, Blog

Certara Compound Registration Performance: Scalability and Speed Across Enterprise Deployments

Certara Products, White Paper

Hidden data gaps in compound registration and drug discovery decisions

Certara Products, Discovery, Guide

Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study

Biologics, Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation - QSP, Therapeutic Specialties, Poster

Mechanistic Modelling of CRS in T-cell Engagers – An Application for Blinatumomab

Certara Services, Clinical Pharmacology, Drug Safety, Model Informed Drug Development, Modeling and Simulation - QSP, Therapeutic Specialties, Poster

Machine Learning based drug renal clearance predictor development and application

AI & Machine Learning, Certara Products - Simcyp, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - PBPK, Poster

Accelerating QSP Virtual Population Generation Through Active Learning and Bayesian Optimization

Certara Services, Clinical Pharmacology, Drug Development, Model Informed Drug Development, Modeling and Simulation, Poster

Chemaxon presents: Too Many Tools, Not Enough Chemistry

Certara Products, On-Demand Webinar

Precursor chemicals – Sine qua non

Cheminformatics, Discovery, Regulatory Strategy, Blog

Mechanistic QSP Modeling to Support KIT Inhibitor Dose Selection, Biomarker Strategy, and Clinical Development

Certara Services, Model Informed Drug Development, Modeling and Simulation, Modeling and Simulation - QSP, Therapeutic Specialties, Poster

Data, models, and modalities: Key themes from the Certainty 2026 Discovery UGM

Certara Products, Model Informed Drug Development, Modeling and Simulation, Blog
ニュースレターを購読

今すぐ登録：医薬品開発の革新は、サターラの情熱そのものです。最新情報を入手し、ともに科学の限界を切り拓いていきましょう。


Powered by Translations.com GlobalLink Web Software